CLB

Core Laboratories Inc

Add to Watchlist

Advanced Chart

10.460

+0.12(1.161%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

10.520

Open

10.340

VWAP

10.43

Vol

340.35K

Mkt Cap

490.51M

Low

10.150

Amount

3.55M

EV/EBITDA(TTM)

8.33

Total Shares

46.66M

584.33M

EV/OCF(TTM)

10.76

P/S(TTM)

0.95

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

122.14M

-1.17%

0.190

+35.71%

131.16M

+1.48%

0.190

-13.64%

132.36M

-1.52%

0.210

-16%

Estimates Revision

The market is revising Upward the revenue expectations for Core Laboratories Inc. (CLB) for FY2025, with the revenue forecasts being adjusted by 0.53% over the past three months. During the same period, the stock price has changed by -5.94%.

Revenue Estimates for FY2025

Revise Upward

+0.53%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.82%

In Past 3 Month

Stock Price

Go Down

-5.94%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast CLB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is 12.50 USD with a low forecast of 12.00 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

0 Sell

Hold

Current: 10.460

Low

12.00

Averages

12.50

High

13.00

Current: 10.460

Low

12.00

Averages

12.50

High

13.00

Stifel

Hold

downgrade

$13 -> $12

2025-07-16

Reason

Stifel

Price Target

$13 -> $12

2025-07-16

downgrade

Hold

Reason

Stifel lowered the firm's price target on Core Laboratories to $12 from $13 and keeps a Hold rating on the shares. Oil service stocks have underperformed the S&P 500 in 2025, and catalysts have been largely negative, the analyst tells investors in a research note. Entering Q2 earnings season, the firm believes shares will be range bound until estimates stop falling.

Citi

Neutral

downgrade

$16 -> $13

2025-05-13

Reason

Citi

Price Target

$16 -> $13

2025-05-13

downgrade

Neutral

Reason

Citi lowered the firm's price target on Core Laboratories to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.

Stifel

Stephen Gengaro

Hold

downgrade

$15 -> $13

2025-04-25

Reason

Stifel

Stephen Gengaro

Price Target

$15 -> $13

2025-04-25

downgrade

Hold

Reason

Stifel analyst Stephen Gengaro lowered the firm's price target on Core Laboratories to $13 from $15 and keeps a Hold rating on the shares after the company delivered "mixed" Q1 results. Growth in Production Enhancement was offset by sluggish Reservoir Description performance, says the firm, which expects second half results to be similar to the first half due to macro uncertainty, tariffs, and oil prices.

Stifel

Stephen Gengaro

Hold

Maintains

$19 → $15

2025-04-15

Reason

Stifel

Stephen Gengaro

Price Target

$19 → $15

2025-04-15

Maintains

Hold

Reason

Citigroup

Scott Gruber

Strong Sell

Hold

Upgrades

$15 → $16

2025-03-12

Reason

Citigroup

Scott Gruber

Price Target

$15 → $16

2025-03-12

Upgrades

Strong Sell

Hold

Reason

Citigroup

Scott Gruber

Strong Sell

Maintains

$14 → $15

2025-02-20

Reason

Citigroup

Scott Gruber

Price Target

$14 → $15

2025-02-20

Maintains

Strong Sell

Reason

Citi raised the firm's price target on Core Laboratories to $15 from $14 and keeps a Sell rating on the shares. The firm updated the company's model post the earnings report.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Core Laboratories Inc (CLB.N) is 13.09, compared to its 5-year average forward P/E of 27.03. For a more detailed relative valuation and DCF analysis to assess Core Laboratories Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

27.03

Current PE

13.09

Overvalued PE

37.44

Undervalued PE

16.63

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

16.08

Current EV/EBITDA

8.99

Overvalued EV/EBITDA

20.95

Undervalued EV/EBITDA

11.21

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

2.01

Current PS

0.93

Overvalued PS

2.67

Undervalued PS

1.34